VIM and head and neck squamous cell carcinoma: In order to evaluate CAF we also performed a co-IF with an anti-∝SMA and an anti-vimentin antibody for two 3D-HNSCC-OTC of HPV-driven HNSCC (HNSCC9 and HNSCC13) and respective primary tumors.